Co-Chairs, Thomas G. Martin, III, MD, and Krina Patel, MD, MSc, discuss multiple myeloma in this CME activity titled “Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/FNM865. CME credit will be available u
Hitting the BCMA Target in Multiple Myeloma
Теги
Thomas G. Martin III MDKrina Patel MD MScmededoncologyhematologymultiple myelomaBCMA-targeted therapiesidecabtagene vicleucelciltacabtagene autoleucelbelantamab mafodotinteclistamabelranatamabtalquetamabunmet needsmultirefractory diseaseCAR-TimmunotherapyQOLhigh-risk diseaseextramedullary diseasecytogenetic risktumor burdensafetyAEsemerging constructscase forumADCsRRMM
